Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Diabetes, Obesity and Metabolism |
| Vol/bind | 23 |
| Udgave nummer | 6 |
| Sider (fra-til) | 1397-1401 |
| Antal sider | 5 |
| ISSN | 1462-8902 |
| DOI | |
| Status | Udgivet - 1 jun. 2021 |
Links
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014019/pdf/DOM-23-1397.pdf
Forlagets udgivne version
ID: 280290468